Company News

LifeView PGT Now New York State Licensed

The LifeView Team

Genomic Prediction Clinical Laboratory will now be able to serve an even greater number of clinicians and patients thanks to recent approval by the state of New York of LifeView PGT.

With more than 140 clinics already utilizing Genomic Prediction's LifeView™ collection of six unique preimplantation tests, the expansion into New York marks...

Genomic Prediction Partners with Help Cure HD

HelpCureHD

A new partnership between HelpCureHD and Genomic Prediction will help couples at risk for Huntington’s Disease (HD) screen for the disease through preimplantation genetic testing. HD is a hereditary brain disorder with no known cure currently. 

 “Our mission at HelpCureHD is to help improve the quality of life for those affected by Huntington’s disease”, says Niki Sims Director of...

Genomic Prediction Promotes Kelly Ketterson to Chief Executive Officer

Kelly Ketterson, CEO, Genomic Prediction

Genomic Prediction announced today that Kelly Ketterson has been promoted to CEO effective immediately. Kelly has served as Genomic Prediction COO since January of this year.

“Kelly’s decades of experience successfully leading at other top companies in the industry, and the enormous progress she’s made here in her last ten months as COO...

Ovation Fertility Licenses Genomic Prediction's LifeView PGT to Provide Patients with the Most Advanced Testing Available

Ovation Fertility

Ovation® Fertility, one of the United States' leading IVF service providers, has announced that it will partner with Genomic Prediction to license the LifeView™ PGT Platform for genetic testing. LifeView PGT provides the most comprehensive genetic test of the preimplantation embryo currently available. Studies comparing LifeView PGT to conventional NGS methods have demonstrated significantly improved clinical outcomes for IVF patients)...

Prospective Parents

We want to be a part of your journey.

contact us
Clinicians

Easily partner with us to improve patient outcomes.

read more
Questions?

We’d love to talk to you!

contact us